Trade Groups Approach MDUFMA Truce? Time To Get Serious About Fee Hikes
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed and the Medical Device Manufacturers Association appear willing to set aside their differences over user fees to ensure that three agreed-upon items make their way into MDUFMA "trigger-fix" legislation this year
You may also be interested in...
GDUFA II Negotiations: Let the Saber-Rattling Begin
The reauthorization of the Generic Drug User Fee Act isn’t going to be as straightforward as the PDUFA process has been for the past two decades. Instead, expect a replay of the first medical device fee renegotiation – with plenty of threats from industry to walk away from the program altogether, likely intended to end up with the best possible deal.
MDUFMA Renewal Plan Spreads Fee Burden More Evenly; Senate Panel OKs
Just two days after FDA released its behind-schedule proposal to reauthorize the medical device user fee program, a Senate committee approved the agency's recommendations to collect almost $300 million from manufacturers through 2012
MDUFMA Renewal Plan Spreads Fee Burden More Evenly; Senate Panel OKs
Just two days after FDA released its behind-schedule proposal to reauthorize the medical device user fee program, a Senate committee approved the agency's recommendations to collect almost $300 million from manufacturers through 2012